Therefore, this study focused on observing the effects of QHF on improving liver injury in NASH by upregulating the expression of SOCS1 to inhibit the TLR4/NF-κB signaling pathway. Here, NFKB1 is linked to metabolic dysfunction-associated steatohepatitis.